Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|August 25, 2006
The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancerKatja Ott, Holger Vogelsang, Noemi Marton, et al.
Annals of Surgical Oncology|January 15, 2014
Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?Ulrike Heger, Susanne Blank, Christiane Wiecha, et al.
Journal of Cancer Research and Clinical Oncology|March 31, 2023
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patientsTheresa Hiltner, Meike Kohlruss, Anna-Lina Herz, et al.
Infection|June 6, 2018
Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysisMarcel Hochreiter, Maria Uhling, Leila Sisic, et al.
International Journal of Cancer|November 29, 2014
Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junctionMargarete Odenthal, Julia Hee, Ines Gockel, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 8, 2017
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?Susanne Blank, Thomas Schmidt, Patrick Heger, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trialChristian Meyer zum Büschenfelde, Ken Herrmann, Tibor Schuster, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 12, 2014
Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputationSusanne Blank, Florian Lordick, Franz Bader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective studyKatja Ott, Ken Herrmann, Florian Lordick, et al.
Pageof 12